Increased Frequency of the Uncommon Allele of a Tumour Necrosis Factor Alpha Gene Polymorphism in Rheumatoid Arthritis and Systemic Lupus Erythematosus

Disease Markers

Volumn 12, Issue 2, 1994, Pages 127-133

  Danish, Victor A ^a   Millingtons, Michelle ^a   Hylands, Valentine ^a   Lawford, Ron ^b   Huang, Qirong ^b   Grennan, David ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Polymorphism; RA; SLE; Tumour necrosis factor

Indexed keywords

CYTOKINE; HLA DR3 ANTIGEN; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0028949049     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/1994/756247     Document Type: Article

References (19)

1. Danis, V., Millington, M. (1994). Gentle separations suit the cell. Today’s Life Sciences, 6, 40–44.
2. Danis, V.A., Millington, M., Grennan, D. (1995). Cytokine production by normal human monocytes: inter-subject variation and relationship to an interleukin-1 receptor antagonist polymorphism. Clin. Exp. Immunol. In press.
3. Danis, V.A., Franic, G.M., Rathjen, D.A., Brooks, P.M. (1991). The effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 2 (IL-2), interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes. Clin. Exp. Immunol., 85, 143–150.
4. Danis, V.A., Kulesz, A.J., Nelson, D.S., Brooks, P.M. (1990). Cytokine regulation of human monocyte interleukin-1 (Il-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha. Clin. Exp. Immunol., 80, 435–443.
5. Elliot, M.J., Maini, R.N., Feldmann, M. Long Fox, A., Charles, P., Katsikis, P., Brennan, F.M., Walker, J., Bijl, H., Ghrayeb, J. et al. (1993). Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumour necrosis factor alpha. Arthritis Rheum., 36, 1681–1690.
6. Fugger, L., Morling, N., Ryder, L.P., Georgsen, J., Jakobsen, B.K., Svejgaard, A., Andersen, V., Oxholm, P., Karup Pedersen, F., Friis, J. et al. (1989). Ncol restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens, 34, 17–22.
7. Grennan, D.M., Dyer, P.A. (1988). Immunogenetics and rheumatoid arthritis. Immunol. Today, 9, 33–34.
8. Grennan, D.M., Parfitt, A., Manolios, N., Huang, Q., Hyland, V., Dunckley, H., Doran, T., Gatenby, P., Badcock, C. (1994). Family and twin studies in Systemic Lupus Erythematosus. Submitted for publication.
9. Jacob, C.O. (1992). Studies on the role of tumor necrosis factor in murine and human autoimmunity. J. Autoimmun., 5 Suppl. A., 133–143.
10. Mansfield, J.C., Holden, H. Tarlow, J.K., di Giovine, F.S., McDowell, T.L., Wilson, A.G., Holdsworth, C.D., Duff, G.W. (1994). Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology, 106, 637–642.
11. Pociot, F., Wilson, A.G., Nerup, J., Duff, G.W. (1993). No independent association between a tumor necrosis factor-alpha promoter region polymorphism and insulin-dependent diabetes mellitus. Eur. J. Immunol., 23, 3050–3053.
12. Ropes, M.W., Bennett, E.A., Cobb, S., Jacox, R., Jessar, R. (1958). Revision of diagnostic criteria for rheumatoid arthritis. Bull. Rheum. Dis., 9, 175–176.
13. Tan, E.M., Cohen, A.S., Fries, J.F., Māsi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 25, 1271–1277.
14. Tomita, Y., Hashimoto, S., Yamagami, K., Sawada, S., Horie, T. (1993). Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). Clin. Exp. Rheumatol., 11, 533–536.
15. Verjans, G.M., Brinkman, B.M., Van Doornik, C.E., Kijlstra, A., Verweij, C.L. (1994). Polymorphism of tumour necrosis factor-alpha (TNFa) at position -308 in relation to ankylosing spondylitis. Clin. Exp. Immunol., 97, 45–47.
16. Wilson, A.G., de Vries, N., Pociot, F., di Giovine, F.S., van der Putte, L.B., Duff, G.W. (1993). An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA-A1, B8 and DR3 alleles. J. Exp. Med., 177, 557–560.
17. Wilson, A.G., di Giovine, F.S., Blakemore, A.I., Duff, G.W. (1992). Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum. Mol. Genet., 1, 353.
18. Wilson, A.G., Gordon, C., de Vries, N., van de Putte, L.B.A., Emery, P., Duff, G.W. (1994). A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur. J. Immunol., 24, 191–195.
19. Wyman, A.R., White, R. (1980). A highly polymorphic locus in human DNA. Proc. Natl. Acad. Sci. USA, 77, 6754–6758.